Literature DB >> 3718915

Iris atrophy in sickle cell disease.

R W Acheson, S M Ford, G H Maude, R W Lyness, G R Serjeant.   

Abstract

Iris atrophy, of unknown origin and believed to be secondary to the vaso-occlusive process of sickle cell disease, has been observed in 25 eyes of 22 patients (two SS disease, 20 SC disease). The crude prevalence was highest in males with SC disease, in whom 14.7% of patients were affected. Iris atrophy was closely associated with proliferative sickle retinopathy in the same eye. Analysis of haematological indices failed to reveal any significant differences between patients with and without iris atrophy. The characteristics and distribution of iris atrophy are described as well as the histopathology in one 68-year-old male patient with SS disease.

Entities:  

Mesh:

Year:  1986        PMID: 3718915      PMCID: PMC1041059          DOI: 10.1136/bjo.70.7.516

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  Iritis and iris atrophy in Herpes zoster ophthalmicus.

Authors:  R J Marsh; D L Easty; B R Jones
Journal:  Am J Ophthalmol       Date:  1974-08       Impact factor: 5.258

2.  Iris atrophy in hemoglobin SC disease.

Authors:  J Chambers; J Puglisi; R Kernitsky; G N Wise
Journal:  Am J Ophthalmol       Date:  1974-02       Impact factor: 5.258

3.  Hemoglobin SC disease and iris atrophy.

Authors:  S Galinos; M F Rabb; M F Goldberg; M Frenkel
Journal:  Am J Ophthalmol       Date:  1973-03       Impact factor: 5.258

4.  Haematological factors associated with proliferative retinopathy in sickle cell-haemoglobin C disease.

Authors:  R J Hayes; P I Condon; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1981-10       Impact factor: 4.638

5.  Iris atrophy after quinine amblyopia.

Authors:  D L Knox; C A Palmer; F English
Journal:  Arch Ophthalmol       Date:  1966-09
  5 in total
  1 in total

1.  Ocular findings in sickle cell patients on Curaçao.

Authors:  J C van Meurs
Journal:  Int Ophthalmol       Date:  1991-01       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.